{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363388845868756608.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1186/1755-8794-6-43"}},{"identifier":{"@type":"URI","@value":"http://link.springer.com/content/pdf/10.1186/1755-8794-6-43.pdf"}},{"identifier":{"@type":"URI","@value":"http://link.springer.com/article/10.1186/1755-8794-6-43/fulltext.html"}},{"identifier":{"@type":"URI","@value":"http://link.springer.com/content/pdf/10.1186/1755-8794-6-43"}}],"dc:title":[{"@value":"Association of candidate single nucleotide polymorphisms with somatic mutation of the epidermal growth factor receptor pathway"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383388845868756608","@type":"Researcher","foaf:name":[{"@value":"Samuel Wormald"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388845868756609","@type":"Researcher","foaf:name":[{"@value":"Liz Milla"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388845868756610","@type":"Researcher","foaf:name":[{"@value":"Liam O’Connor"}]}],"publication":{"publicationIdentifier":[{"@type":"EISSN","@value":"17558794"}],"prism:publicationName":[{"@value":"BMC Medical Genomics"}],"dc:publisher":[{"@value":"Springer Science and Business Media LLC"}],"prism:publicationDate":"2013-10-23","prism:volume":"6","prism:number":"1","prism:startingPage":"43"},"reviewed":"false","dc:rights":["http://www.springer.com/tdm"],"url":[{"@id":"http://link.springer.com/content/pdf/10.1186/1755-8794-6-43.pdf"},{"@id":"http://link.springer.com/article/10.1186/1755-8794-6-43/fulltext.html"},{"@id":"http://link.springer.com/content/pdf/10.1186/1755-8794-6-43"}],"createdAt":"2013-10-23","modifiedAt":"2019-07-31","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Genetics%20(clinical)","dc:title":"Genetics (clinical)"},{"@id":"https://cir.nii.ac.jp/all?q=Genetics","dc:title":"Genetics"}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360002220793703424","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Augmentation of antibody-dependent cellular cytotoxicity with defucosylated monoclonal antibodies in patients with GI-tract cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1361412889595788672","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"[fam‐] trastuzumab deruxtecan, antitumor activity is dependent on HER2 expression level rather than on <i>HER2</i> amplification"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1186/1755-8794-6-43"},{"@type":"CROSSREF","@value":"10.3892/ol.2017.7556_references_DOI_J1XXCbV9kUtrOq40ydFvOcAyn2i"},{"@type":"CROSSREF","@value":"10.1002/ijc.32408_references_DOI_J1XXCbV9kUtrOq40ydFvOcAyn2i"}]}